当前位置：   首页 > 需求大厅

 >  特色服务 

 >  信息服务 

药物研发中心全套质量管理体系文件，越详细越好，价格可谈！   [更多]

1、Drugs Fut 1989, 14(9): 875 ISSN 0377-8282 Copyright Clarivate Analytics CCC: 0377-8282 DOI: 10.1358/dof.1989.014.09.103408 2、Dionne, G. (BioChem Pharma Inc.); 1,3-Oxathiolane nucleoside analogues. EP 0526253; JP 1995500317; US 5538975; WO 9303027 . 3、Hoshi, A.; Castañer, J.; Capecitabine. Drugs Fut 1996, 21, 4, 358 4、Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1997, vol. 36, # 9, p. 816 - 818 5、DETERMINATION OF CLENBUTEROL HYDROCHLORIDE BY SEQUENTIAL INJECTION ANALYSIS COUPLED WITH CHEMILUMINESCENCE DETECTION 6、[Bioanalytic examination and pharmacokinetics of captopril. Bioequivalence studies of different captopril-containing Tensiomin preparations]. 7、Agrati A. M., De Bartolo G., Palmieri G., Minerva Med., 83, 533-536(1992) 8、Dawes J., Hodson B. A., Pepper D. S., Thromb. Haemost, 62, 945-949(1989) 9、with mercury(II) diacetate,trifluoroacetic acid . Acta Chimica Hungarica 1986 vol.122 3-4 p261-272   [更多]

1.Arzneimittel Forschung/Drug research 1986 36(2)，p291-303. 2.The use of antithrombotic drugs in artery disease 3. Jonassen IB, Havelund S, Ribel U, et al. Insulin Degludec is a new generation ultra-long acting basal insulin with a unique mechanism of protraction based on multi-hexamer ormation [J]. Diabetes, 2010, 59(Suppll): All(39-OR). 4.Korsatko S, Deller S, Zahiragic S, et al. Ultra-long-acting insulin degludec: two different formulations (U100 and U200) are bioequivalent and show similar pharmacodynamics [abstract no. 2349-PO]. Diabetes. 2011;60 Suppl:A624. 5.Technology Reports of the Osaka University, , vol. 7, p. 177,182。   [更多]

1、P. A. Prajapati and M. M. Patel, “Formulation and in vitro evaluation of atropine sulphate viscous ocular solutions for the mydriatic and cycloplegic effect,” International Journal of Pharmaceutical and Applied Sciences, vol. 1, no. 2, pp. 70–78, 2010. View at Google Scholar 2、D. S. Satya, K. P. Suria, and P. P. Muthu, “Advanced approaches and evaluation of ocular drug delivery system,” American Journal of PharmTech Research, vol. 1, no. 4, pp. 72–92, 2011. View at Google Scholar 3、B. K. Nanjwade, D. B. Sonaje, and F. V. Manvi, “In vitro—in vivo release of ciprofloxacin from ophthalmic formulations,” International Journal of Pharmacy and Biotechnology, vol. 1, no. 1, pp. 23–28, 2011. View at Google Scholar 4、Physicochemical properties and stability of nicorandil By Nagai, Hiroshi; Koizumi, Ikue; Haneda, Masatoshi; Imai, Toshikatsu; Kikuchi, Mineo; Shiba, Motoharu From Iyakuhin Kenkyu (1983), 14(6), 968-79. Language: Japanese, Database: CAPLUS 5、Sobean oil partially hydrogenated 最新德国药典   [更多]

1.Myopia Control with Bifocal Contact Lenses: A Randomized Clinical Trial 2.The Role of Atropine Eye Drops in Myopia Control 4. Myopia Control: A Review 7. Efficacy of 1% atropine eye drops in retarding progressive axial myopia in Indian eyes 8.Atropine 0.01% Eyedrops Significantly Reduce the Progression of Childhood Myopia 9.Current approaches to myopia control 10.Atropine for the Prevention of Progression in Myopia - Data, Side Effects, Practical Guidelines 13. Atropine 0.01% Eyedrops Significantly Reduce the Progression of Childhood Myopia. 18. The treatment of myopia with atropine and bifocals. A long-term prospective study 19. Inhibitory effects of apomorphine and atropine and their combination on myopia in chicks 20. The penetration and distribution of topical atropine in animal ocular tissues. 21. Treatment outcomes of myopic anisometropia with 1% atropine: a pilot study 23. Does atropine use increase intraocular pressure in myopic children? 24. Atropine use for the prevention of myopia progression 25. Allergic reactions to atropine eye drops for retardation of progressive myopia in children. 29. Maximum atropine dose without clinical signs or symptoms. 31. Atropine and bifocals can slow the progression of myopia in children. 33. Prevention of myopia onset with 0.025% atropine in premyopic children 35. The long-term results of using low-concentration atropine eye drops for controlling myopia progression in schoolchildren. 37. Prevention of myopia progression with 0.05% atropine solution.   [更多]

1、Effect of probenecid or diet on tebipenem pivoxil tablets pharmacokinetics in healthy male volunteers； 2、Effect of diet on the pharmacokinetics of tebipenem pivoxil fine granules in healthy male volunteers； 3、Pharmacokinetics analysis of tebipenem pivoxil in a phase II clinical trial in otolaryngological infection 1、Pharmacokinetic properties of isosorbide-5-mononitrate under fasting and fed conditions in healthy male subjects. Jin C, Jeon JY, Im YJ, Jeong JA, Kim Y, Chae SW, Bentz J, Kumke T, Kim MG. 7.The control of myopia with atropine.   [更多]

根据已知省份、城市的医院销售数据样本，根据样本数据如何计算医院销售数据在全国的销售量、销售额？ 放大规则提供相关原理，思路，计算中所需要的样本变量（字段，如：如“某药品的药品销售额”与“样本对于省份”，“样本城市数量”、“样本医院数量”、“样本医院等级比例”等的关系），以及相关规格参数以及参数计算的方式，具体细节可私下沟通。   [更多]

1、American Conference of Governmental Industrial Hygienists TLVs and BEIs. Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices. Cincinnati, OH, 2008, 2、内容：Totsuka K，Furukawa M，Furuya N，et al. PK/PD analysis of Tebipenem Pivoxil (ME1211),a Novel Oral Carbapenem Antibiotic,in otolaryngological infections,a phase II clinical trial （3）.45th Intersci Conf Antimicrob Agents Chemother（ICAAC）（Dec 16-19. Washington，D.C.），2005，Abst L-579标题 PK/PD analysis of Tebipenem Pivoxil (ME1211),a Novel Oral Carbapenem Antibiotic,in otolaryngological infections,a phase II clinical trial； 3、PK–PD analysis of tebipenem pivoxil in clinical trials for pediatric patients. Jpn J Chemother. 2009;57(S-1):186–91. 4、Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system. González MA1, Straughan AB. 5、Single dose study of the bioequivalence of two sustained-release theophylline formulations. Contreras J, Pérez N, González R, Ontivero E, López M. Arzneimittelforschung. 1998 Mar;48(3):259-62. 6、National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific & Technical Information., AD277-689 7、Graul, A.; Castaner, J.; Atorvastatin Calcium. Drugs Fut 1997, 22, 9, 956. 8、Formulation And Evaluation of Topical Aceclofenac Gel Using Different Gelling Agent（JAPAN PATEL1*, BRIJESH PATEL1, HARDEEPSINGH BANWAIT1, KAUSHAL PARMAR1,MANISH PATEL2 Department of Pharmaceutics, Sat Kaival College of Pharmacy, Sarsa, Anand, Gujarat, India Nootan Pharmacy College, Visnagar, Gujarat, India） 9、NCCN pediatric neuroblastoma practice guidelines. The National Comprehensive Cancer Network. Oncology (Williston Park). 1996 Dec;10(12):1813-22 10、Preliminary studies on toxic effects of some vulcanizing accelerators 11、Dose Dumping Dose dumping is an increased concern with drugs manufactured as modified-release (MR) formulations, that is, where drug   [更多]

1、托伐普坦治疗ADPKD临床实践指南解读 2、Severino B, Luisi G, Donomae Iwamoto R, Moreno RA, Perez Teixeira V, Di Vaio P, Saccone I, Magli E, Santagada V, Caliendo G, Mendes GD, De Nucci G. 3、Executive summary on acetaminophen efficacy and safety. McNeil Consumer & SpecialtyPharmaceuticals. Data on file. 2002-9-19. Nonprescription Drugs Advisory Committee Meeting 2002 8 20 4、Polymorphism and pseudopolymorphism on nifedipine 5、Ullmann, vol.18, p.223 1979年的文献 6、Pharmacokinetics/dynamics following administration of a recombinant humanized monoclonal anti IgE antibody in the cynomolgus monkey   [更多]

上海市计生所需要一份醋酸戈舍瑞林缓释植入剂的信息   [更多]